Cumberland Pharmaceuticals (NASDAQ:CPIX) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX) in a research note released on Thursday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock.

Cumberland Pharmaceuticals Price Performance

Shares of NASDAQ:CPIX opened at $1.58 on Thursday. The firm has a 50 day simple moving average of $1.78 and a 200 day simple moving average of $1.86. The company has a market cap of $22.40 million, a price-to-earnings ratio of -3.59 and a beta of 0.17. Cumberland Pharmaceuticals has a one year low of $1.42 and a one year high of $2.36. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.28 and a quick ratio of 1.11.

Cumberland Pharmaceuticals (NASDAQ:CPIX) last announced its quarterly earnings results on Tuesday, March 5th. The specialty pharmaceutical company reported ($0.12) EPS for the quarter. The firm had revenue of $9.35 million during the quarter. Cumberland Pharmaceuticals had a negative net margin of 15.87% and a positive return on equity of 6.84%.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Cumberland Pharmaceuticals stock. Bank of New York Mellon Corp bought a new position in shares of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund bought 75,268 shares of the specialty pharmaceutical company’s stock, valued at approximately $142,000. Bank of New York Mellon Corp owned about 0.52% of Cumberland Pharmaceuticals at the end of the most recent reporting period. Institutional investors own 15.51% of the company’s stock.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.